Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-EN Version v1-EN
Language English English
Date Updated 2018-11-02 2017-05-05
Drug Identification Number 02238348 02238348
Brand name RESCRIPTOR RESCRIPTOR
Common or Proper name delavirdine mesylate tablet delavirdine mesylate tablet
Company Name VIIV HEALTHCARE ULC VIIV HEALTHCARE ULC
Ingredients DELAVIRDINE MESYLATE DELAVIRDINE MESYLATE
Strength(s) 100MG 100MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL
Packaging size 360s 360s
ATC code J05AG J05AG
ATC description DIRECT ACTING ANTIVIRALS DIRECT ACTING ANTIVIRALS
Reason for discontinuation Raw material availability Raw material availability
Anticipated discontinuation date 2018-11-01
Actual discontinuation date 2018-11-01
Remaining supply date 2019-04-30 2019-04-30
Discontinuation status Discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments
Health Canada comments